Close Menu

Celgene

NEW YORK (GenomeWeb News) – Epic Sciences, which is developing diagnostics to identify and characterize rare cells, said today it is collaborating with six drug manufacturers to develop companion diagnostic tools.

NEW YORK (GenomeWeb News) – The Smithsonian Institution's National Museum of Natural History will collaborate with the National Human Genome Research Institute to open an exhibit next year that will highlight human genomics at its museum on the National Mall, leaders from the two institutes said

Epizyme is hoping that its new partnership with Celgene International Sarl will bolster the development and commercialization of its pipeline of personalized treatments that inhibit histone methyltransferase enzymes associated with specific genetic alterations.

The goal is to use the test to enable targeted recruitment of patient populations and to stratify patients based on their mutational profile to identify those most likely to respond to Celgene's drug candidates.

Foundation's test will be used to hasten faster recruitment of target patient populations and for broad genetic characterization of trial enrollees to identify those most likely to respond to Celgene's drug candidates.

Celgene said the center — its first outside the US exclusively dedicated to R&D — will carry out research in cell signaling, cellular therapies, tumor biobanking, epigenetics, and bioinformatics.

A total of six facilities comprising more than 2 million square feet are in New York's pipeline of life-sci space, according to the panelists who spoke at the New York Biotechnology Association's annual meeting this week.

Pages

China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.

23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.

In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.

NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.